Skip to main content

Advertisement

SpringerLink
Log in

Cytotoxic effects of statins and thiazolidinediones on meningioma cells

  • Laboratory Investigation - Human/Animal Tissue
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Statins are inhibitors of the cholesterol synthesis pathway with pleiotropic effects, while thiazolidinediones (TDZ) are peroxisomal proliferator activator receptor γ (PPAR-γ) agonists with potent proapoptotic activity. For both groups of substances a cytotoxic effect against several human tumors is presumed. Direct comparison of several statins and TDZ has not been performed on meningioma cells until now. We compared the antiproliferative/cytotoxic effect of five statins, two TDZ, and their combinations on various human meningioma cell lines and nontumorous cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, cell cycle analysis, and caspase-3 assay. Simvastatin (SMV) and its combination with the TDZ pioglitazone (PGZ) turned out to be the most effective treatment. After 96 h the 50% inhibition concentration (IC50) of SMV in MTT assays for two more sensitive meningioma cell lines (one benign and one malignant) was below 0.9 μM, while the IC50 was 2.8 μM or higher for two other meningioma lines. Fluorescence-activated cell sorting (FACS) analysis suggested that MTT results mostly represented cytotoxic rather than antiproliferative effects. Strong caspase-3 induction suggested participation of intrinsic apoptosis in meningioma cell death. In contrast, SMV showed no substantial effects on fibroblasts and astrocytes. Addition of 40 μM PGZ significantly decreased the fraction of clonogenic cells in soft-agar assays, as compared with 2.8 μM SMV alone. Taken together, SMV showed a significant cytotoxic effect against human meningioma cells, which was moderately enhanced by PGZ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Kalamarides M, Stemmer-Rachamimov AO, Takahashi M, Han ZY, Chareyre F, Niwa-Kawakita M et al (2008) Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. Brain Pathol 18(1):62–70

    Article  PubMed  Google Scholar 

  2. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20(1):22–39

    Article  PubMed  CAS  Google Scholar 

  3. Jaaskelainen J (1986) Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26(5):461–469

    Article  PubMed  CAS  Google Scholar 

  4. Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P et al (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95(3):367–375

    Article  PubMed  Google Scholar 

  5. Schrell UM, Rittig MG, Anders M, Koch UH, Marschalek R, Kiesewetter F et al (1997) Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 86(5):840–844

    Article  PubMed  CAS  Google Scholar 

  6. Newton HB (2007) Hydroxyurea chemotherapy in the treatment of meningiomas. Neurosurg Focus 23(4):E11

    Article  PubMed  Google Scholar 

  7. Hindler K, Cleeland CS, Rivera E, Collard CD (2006) The role of statins in cancer therapy. Oncologist 11(3):306–315

    Article  PubMed  CAS  Google Scholar 

  8. Jiang Z, Zheng X, Lytle RA, Higashikubo R, Rich KM (2004) Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells. J Neurochem 89(1):168–178

    Article  PubMed  CAS  Google Scholar 

  9. Cemeus C, Zhao TT, Barrett GM, Lorimer IA, Dimitroulakos J (2008) Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status. J Neurooncol 90(1):9–17

    Article  PubMed  CAS  Google Scholar 

  10. Johnson MD, Woodard A, Okediji EJ, Toms SA, Allen GS (2002) Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase. J Neurooncol 56(2):133–142

    Article  PubMed  Google Scholar 

  11. Mawrin C, Sasse T, Kirches E, Kropf S, Schneider T, Grimm C et al (2005) Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas. Clin Cancer Res 11(11):4074–4082

    Article  PubMed  CAS  Google Scholar 

  12. Chou FS, Wang PS, Kulp S, Pinzone JJ (2007) Effects of thiazolidinediones on differentiation, proliferation, and apoptosis. Mol Cancer Res 5(6):523–530

    Article  PubMed  CAS  Google Scholar 

  13. Spagnolo A, Grant EN, Glick R, Lichtor T, Feinstein DL (2007) Differential effects of PPARgamma agonists on the metabolic properties of gliomas and astrocytes. Neurosci Lett 417(1):72–77

    Article  PubMed  CAS  Google Scholar 

  14. Papi A, Tatenhorst L, Terwel D, Hermes M, Kummer MP, Orlandi M et al (2009) PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models. J Neurochem 109(6):1779–1790

    Article  PubMed  CAS  Google Scholar 

  15. Yao CJ, Lai GM, Chan CF, Cheng AL, Yang YY, Chuang SE (2006) Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone. Int J Cancer 118(3):773–779

    Article  PubMed  CAS  Google Scholar 

  16. Haase D, Schmidl S, Ewald C, Kalff R, Huebner C, Firsching R et al. Fatty acid synthase as a novel target for meningioma therapy. p. noq004

  17. Mason RP, Walter MF, Day CA, Jacob RF (2005) Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions. Am J Cardiol 96(5A):11F–23F

    Article  PubMed  CAS  Google Scholar 

  18. Sironi L, Gianazza E, Gelosa P, Guerrini U, Nobili E, Gianella A et al (2005) Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects. Arterioscler Thromb Vasc Biol 25(3):598–603

    Article  PubMed  CAS  Google Scholar 

  19. Grommes C, Landreth GE, Sastre M, Beck M, Feinstein DL, Jacobs AH et al (2006) Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment. Mol Pharmacol 70(5):1524–1533

    Article  PubMed  CAS  Google Scholar 

  20. Spagnolo A, Glick RP, Lin H, Cohen EP, Feinstein DL, Lichtor T (2007) Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts. J Neurosurg 106(2):299–305

    Article  PubMed  CAS  Google Scholar 

  21. Xue YJ, Turner KC, Meeker JB, Pursley J, Arnold M, Unger S (2003) Quantitative determination of pioglitazone in human serum by direct-injection high-performance liquid chromatography mass spectrometry and its application to a bioequivalence study. J Chromatogr B Analyt Technol Biomed Life Sci 795(2):215–226

    Article  PubMed  CAS  Google Scholar 

  22. Striedinger K, Vandenberg SR, Baia GS, McDermott MW, Gutmann DH, Lal A (2008) The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Neoplasia 10(11):1204–1212

    PubMed  CAS  Google Scholar 

  23. Zacco A, Togo J, Spence K, Ellis A, Lloyd D, Furlong S et al (2003) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci 23(35):11104–11111

    PubMed  CAS  Google Scholar 

  24. Johnson M, Toms S (2005) Mitogenic signal transduction pathways in meningiomas: novel targets for meningioma chemotherapy? J Neuropathol Exp Neurol 64(12):1029–1036

    Article  PubMed  CAS  Google Scholar 

  25. Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ et al (1996) Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res 2(3):483–491

    PubMed  CAS  Google Scholar 

  26. Gabrys D, Doerfler A, Yaromina A, Hessel F, Krause M, Oertel R, Baumann M (2008) Effects of lovastatine alone or combined with irradiation on tumor cells in vitro and in vivo. Strahlenther Onkol 184:48–53

    Google Scholar 

  27. Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S (1997) Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneimittelforschung 47(1):29–35

    PubMed  CAS  Google Scholar 

  28. Bitzer M, Nagele T, Geist-Barth B, Klose U, Gronewaller E, Morgalla M et al (2000) Role of hydrodynamic processes in the pathogenesis of peritumoral brain edema in meningiomas. J Neurosurg 93(4):594–604

    Article  PubMed  CAS  Google Scholar 

  29. Vignes JR, Sesay M, Rezajooi K, Gimbert E, Liguoro D (2008) Peritumoral edema and prognosis in intracranial meningioma surgery. J Clin Neurosci 15(7):764–768

    Article  PubMed  CAS  Google Scholar 

  30. Cafforio P, Dammacco F, Gernone A, Silvestris F (2005) Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 26(5):883–891

    Article  PubMed  CAS  Google Scholar 

  31. Dimitroulakos J, Marhin WH, Tokunaga J, Irish J, Gullane P, Penn LZ et al (2002) Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas. Neoplasia 4(4):337–346

    Article  PubMed  CAS  Google Scholar 

  32. Agarwal B, Bhendwal S, Halmos B, Moss SF, Ramey WG, Holt PR (1999) Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin Cancer Res 5(8):2223–2229

    PubMed  CAS  Google Scholar 

  33. Dimitroulakos J, Thai S, Wasfy GH, Hedley DW, Minden MD, Penn LZ (2000) Lovastatin induces a pronounced differentiation response in acute myeloid leukemias. Leuk Lymphoma 40(1–2):167–178

    Article  PubMed  CAS  Google Scholar 

  34. Chan DY, Chen GG, Poon WS, Liu PC (2008) Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis. J Neurooncol 86(3):273–283

    Article  PubMed  CAS  Google Scholar 

  35. Tanaka T, Tatsuno I, Uchida D, Moroo I, Morio H, Nakamura S et al (2000) Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition. J Neurosci 20(8):2852–2859

    PubMed  CAS  Google Scholar 

  36. Perez-Ortiz JM, Tranque P, Vaquero CF, Domingo B, Molina F, Calvo S et al (2004) Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma. J Biol Chem 279(10):8976–8985

    Article  PubMed  CAS  Google Scholar 

  37. Kondo M, Oya-Ito T, Kumagai T, Osawa T, Uchida K (2001) Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J Biol Chem 276(15):12076–12083

    Article  PubMed  CAS  Google Scholar 

  38. Baia GS, Dinca EB, Ozawa T, Kimura ET, McDermott MW, James CD et al (2008) An orthotopic skull base model of malignant meningioma. Brain Pathol 18(2):172–179

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported in part by a grant from the Deutsche Krebshilfe to C.M. and E.K. (grant number 108987).

Author information

Authors and Affiliations

  1. Department of Neuropathology, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany

    Sonja Gehring, Elmar Kirches & Christian Mawrin

  2. Department of Neurosurgery, Otto-von-Guericke University Magdeburg, Magdeburg, Germany

    Sonja Gehring, Jorge Humberto Tapia-Pérez, Raimund Firsching & Thomas Schneider

  3. Department of Biochemistry and Cell Biology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany

    Gerburg Keilhoff

Authors
  1. Sonja Gehring
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorge Humberto Tapia-Pérez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elmar Kirches
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raimund Firsching
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gerburg Keilhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Thomas Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Christian Mawrin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Mawrin.

Additional information

Authors Thomas Schneider and Christian Mawrin contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gehring, S., Tapia-Pérez, J.H., Kirches, E. et al. Cytotoxic effects of statins and thiazolidinediones on meningioma cells. J Neurooncol 102, 383–393 (2011). https://doi.org/10.1007/s11060-010-0351-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-010-0351-1

Keywords

Search

Navigation